Troponin Rapid Tests and Point of Care (POC) Pipeline Report including Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies, 2021
Powered by
All the vital news, analysis, and commentary curated by our industry experts.
Troponin rapid tests & point of care (POC) are point-of-care diagnostic tests that enable to the measurement of troponin levels specific to cardiovascular diseases in a patient’s sample. The troponin rapid tests & point of care pipeline product market report provides key information and data related to extensive coverage of the troponin rapid tests & point of care under development. The report also provides details of major pipeline products which include product description, licensing and collaboration details, and other developmental activities including pipeline territories, regulatory paths, and estimated approval dates.
Which are the key territories in the troponin rapid tests & point of care pipeline product market?
The US is the leading country in the troponin rapid tests & point of care pipeline product market with the highest number of pipeline products followed by Europe, New Zealand, Australia, and China.
Troponin rapid tests & point of care pipeline product market, by territory
For more territorial insights, download a free sample
Which are the key regulatory paths in the troponin rapid tests & point of care pipeline product market?
510(k), CE-IVD, TGA, NMPA are the key regulatory paths used in the troponin rapid tests & POC pipeline product market. 510(k) was the most popular regulatory path in the troponin rapid tests & POC pipeline product market followed by CE-IVD, TGA, and NMPA.
Troponin rapid tests & point of care pipeline product market, by regulatory path
For more key regulatory phase insights, download a free sample
Which are the key companies in the troponin rapid tests & point of care pipeline product market?
The rapid tests & POC pipeline products market report offers detailed information on pipeline products of several companies including Abbott Point of Care Inc, Angle Biosciences Inc, Anteo Technologies Pty Ltd, BBB Technologies Inc, Bio-AMD Inc, Bluejay Diagnostics Inc, Carclo Diagnostic Solutions Ltd, Group K Diagnostics, LumiraDx Ltd, and MML Ltd.
Abbott Point of Care Inc: Abbott Point of Care Inc (Abbott Point), a subsidiary of Abbott Laboratories, is a medical device company that offers diagnostic products. The company manufactures, develops, and distributes medical diagnostic and data management products for in-vitro diagnostic and healthcare markets. Its products comprise of handheld blood analyzers, cardiac markers, lactate, blood gases, electrolytes, lab information systems, electronic medical recording systems, and automated clinical chemistry systems
Angle Biosciences Inc: Angle Biosciences Inc (Angle Biosciences), formerly Axela Inc, is a provider of optic technology solutions. The company offers Ziplex system, Flow-thru TipChips, panelPlus TipChips, diffractive optics technology, diffractive optics sensors, panelPlus sensors, and software products. It offers technical and application support, on-site and in-house training, extended warranty, service and maintenance contracts, and custom application development services.
Anteo Technologies Pty Ltd: Anteo Technologies Pty Ltd (Anteo) is focused on developing and commercializing high-value opportunities for the company’s core technology and has existing products in the life sciences research and in-vitro-diagnostics markets.
BBB Technologies Inc
BBB Technologies Inc (BBB Tech) is a development-stage medical technology company that develops medical devices and applications that facilitate the early diagnosis of metabolic and cardiovascular disorders. It discovers and develops single-drop and mobile integrated diagnostic tools for blood testing.
Troponin rapid tests & point of care pipeline product market, by company
To know more about key companies, download a free sample
Market report scope
Segment by stage of development | Early Development, Clinical, In Approval Process, and Inactive |
Segment by territory | The US, Europe, New Zealand, Australia, and China |
Segment by regulatory path | 510(k), CE-IVD, TGA, and NMPA |
Key companies | Abbott Point of Care Inc, Angle Biosciences Inc, Anteo Technologies Pty Ltd, BBB Technologies Inc, Bio-AMD Inc, Bluejay Diagnostics Inc, Carclo Diagnostic Solutions Ltd, Group K Diagnostics, LumiraDx Ltd, and MML Ltd |
Scope
- Extensive coverage of the troponin rapid tests & point of care under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details, and other developmental activities
- The report reviews the major players involved in the development of troponin rapid tests & point of care and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from early development to approved/issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment/industry
Reasons to Buy
The report enables you to:
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with the potentially strong product portfolio and create effective counter-strategies to gain a competitive advantage
- Identify and understand important and diverse types of troponin rapid tests & point of care under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory, and estimated launch date
Angle Biosciences Inc
Anteo Technologies Pty Ltd
BBB Technologies Inc
Bio-AMD Inc
Bluejay Diagnostics Inc
Carclo Diagnostic Solutions Ltd
Group K Diagnostics
LumiraDx Ltd
MML Ltd
Nanomix Inc
Ohmx Corp
OPKO Health Inc
Proxim Diagnostics Corp
Resdin Technologies Inc.
Sandia National Laboratories
SpinChip Diagnostics AS
Table of Contents
Table
Figures
Frequently asked questions
-
Which are the key territories in the troponin rapid tests & point of care pipeline product market?
The key territories in the troponin rapid tests & POC market are the US, Europe, New Zealand, Australia, and China.
-
Which are the key regulatory paths for the troponin rapid tests & point of care pipeline product market?
510(k), CE-IVD, TGA, NMPA are the key regulatory paths for the troponin rapid tests & POC market.
-
Which are the key companies in the troponin rapid tests & point of care pipeline product market?
The key companies in the troponin rapid tests & POC market are Abbott Point of Care Inc, Angle Biosciences Inc, Anteo Technologies Pty Ltd, BBB Technologies Inc, Bio-AMD Inc, Bluejay Diagnostics Inc, Carclo Diagnostic Solutions Ltd, Group K Diagnostics, LumiraDx Ltd, and MML Ltd.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.